Emerging Threat: The ‘Cicada’ Variant and Its Implications
A new variant of the SARS-CoV-2 virus, known as BA.3.2 or ‘Cicada’, is raising concerns among health officials in the UK. This strain has already begun to spread rapidly in the United States and has been detected in 23 other countries, including the UK. While the exact number of cases in the UK remains undisclosed, experts are worried about the mutations this variant carries, which could allow it to evade immune defenses provided by existing vaccines.
Symptoms and Vulnerability
The symptoms associated with the ‘Cicada’ variant are similar to those of the original virus, including extreme fatigue, fever, and body aches. However, school-aged children appear to be more susceptible to this strain. Professor Stephen Griffin, a viral oncologist at the University of Leeds, has pointed to what he calls ‘short-sighted’ advice from the Joint Committee on Vaccination and Immunisation (JCVI) regarding the inclusion of vaccines for children.
He stated:
“At present the dynamics of this virus don’t appear consistent with a fast-growing epidemic wave, more of a slow-building one we saw last year. Nevertheless, more infection means more rolls of the dice and a greater chance that more advantageous changes may occur. The risk of reinfection and juvenile long Covid were not taken into account back then and as such we must remember that many people remain relatively unprotected by vaccines.”

Professor Griffin further emphasized the need for regular boosters and the inclusion of Covid vaccines in preschool immunization programs, drawing a comparison to the influenza vaccination schedule.
Genetic Mutations and Public Health Concerns
Analysis suggests that the ‘Cicada’ variant’s spike protein has undergone around 75 mutations, making it a significant threat to the immune system. However, not all experts are convinced that this will lead to an increase in deaths. Professor Paul Hunter, a microbiologist at the University of East Anglia, explained:
“It is not surprising that a new variant has been described. The issue is whether the new variant poses a significant increased risk to public health. It is likely that any new variant that is able to out-compete the other variants will increase infection rates but that does not mean this will necessarily lead to substantial additional burden of the disease.”

One reason for this cautious outlook is that mutations do not always help the virus spread more effectively. Instead, experts are concerned about declining vaccination rates. Professor Griffin noted:
“Yes, there will be a high degree of ‘mismatch’ between BA.3.2.2 and current vaccines, which is unfortunate, and may mean the population as a whole experience more infections. However, at present we don’t seem to be on the brink of a pandemic.”
Controversy Over Childhood Vaccinations
Offering the Covid jabs to children during the pandemic was initially controversial. Some studies suggested that two doses of the vaccines offered only 10% protection against certain strains. Initially, the JCVI ruled against offering the vaccines to healthy children, citing their low risk of severe illness. However, the committee later changed its stance, approving the jabs to protect schooling and prevent disruptions to education.
Since then, government officials have consistently stated they will avoid imposing lockdowns unless a highly dangerous variant emerges. A strong wall of immunity, built through repeated waves of infection and vaccine rollouts, has given officials confidence in moving away from pandemic-era measures.
Current Situation and Future Outlook
While spikes in cases can still cause widespread illness and disruption, officials no longer track the prevalence of the virus as intensively as before. According to the latest figures, only 2% of cases in England have been linked to the BA.3.2.2 strain. In the UK, overall Covid cases remain low, with fewer than 500 reported cases.
Experts continue to monitor the situation closely, emphasizing the importance of maintaining vaccination efforts and being prepared for potential future challenges.






